Ami Organics Limited
NSE: AMIORG · Specialty Chemicals
Snapshot
Unlock Ami Organics Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Ami Organics Limited is a research-driven manufacturer specialising in pharmaceutical intermediates and specialty chemicals. The company serves diverse sectors including healthcare, cosmetics, animal nutrition, and agrochemicals through a portfolio of approximately 450 products.
Business Model
The company generates revenue through the research, development, and large-scale manufacturing of complex chemical intermediates. It operates as a supplier to both domestic and international markets, catering to regulated and generic pharmaceutical manufacturers as well as industrial specialty chemical users.
- Product Portfolio:450+ intermediates
Growth Outlook
Growth is driven by the expansion of its pharmaceutical intermediate portfolio and the increasing demand for specialty chemicals in the cosmetics and agrochemical sectors. The company continues to leverage its R&D capabilities to enter new chemical entities and strengthen its export footprint.
Key Risks
- Regulatory Compliance. The company is subject to stringent environmental and quality regulations in both domestic and international markets, which may impact operational costs.
- Raw Material Price Volatility. Fluctuations in the prices of key chemical feedstocks can significantly impact profit margins due to the company's reliance on global supply chains.
- Customer Concentration. A significant portion of revenue is derived from a limited number of pharmaceutical clients, making the company vulnerable to changes in their procurement strategies.
- Foreign Exchange Risk. As an exporter, the company faces exposure to currency fluctuations that can affect the competitiveness and profitability of its international sales.
Price
Start your research today
Unlock AI insights, financials, peers and live data on Ami Organics Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹1,339 Cr
TTM · consolidated
NET PROFIT
₹356 Cr
TTM · consolidated
EPS
₹43.51
TTM · consolidated
RETURN ON EQUITY
25.5%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
33.6%
TTM · consolidated
P/E
27.0x
Q4 FY26 · consolidated
EV/EBITDA
18.1x
Q4 FY26 · consolidated
EBITDA MARGIN
39.0%
TTM · consolidated
NET PROFIT MARGIN
31.0%
Q4 FY26 · consolidated
DEBT TO EQUITY
0.0x
Q4 FY26 · consolidated
Peers · Specialty Chemicals
| Company | Mkt Cap (Cr) | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Ami Organics LimitedAMIORG | 9,630 | 27.04 | 18.09 | 33.0% | 39.0% | 25.5% | 33.6% | — |
Privi Speciality Chemicals LimitedPRIVISCL | 11,488 | 44.28 | 23.24 | 22.0% | 26.0% | 26.8% | 29.2% | +55.2% |
Jubilant Ingrevia Ltd.JUBLINGREA | 9,086 | 43.12 | 20.68 | 5.0% | 13.8% | 9.3% | 11.3% | -7.6% |
Archean Chemical Industries LimitedACI | 7,474 | 63.41 | 27.11 | 3.8% | 24.6% | 5.6% | 7.8% | -21.0% |
Clean Science and Technology Ltd.CLEAN | 7,473 | 35.56 | 21.00 | -1.1% | 40.5% | 15.7% | 20.8% | -47.3% |
Alkyl Amines Chemicals Ltd.ALKYLAMINE | 7,306 | 53.67 | 30.25 | -2.3% | 20.6% | 12.5% | 15.5% | -18.2% |
As of Q4 FY26
Financials
Ami Organics Limited
NSE: AMIORG · Specialty Chemicals
Snapshot
Unlock Ami Organics Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Ami Organics Limited is a research-driven manufacturer specialising in pharmaceutical intermediates and specialty chemicals. The company serves diverse sectors including healthcare, cosmetics, animal nutrition, and agrochemicals through a portfolio of approximately 450 products.
Business Model
The company generates revenue through the research, development, and large-scale manufacturing of complex chemical intermediates. It operates as a supplier to both domestic and international markets, catering to regulated and generic pharmaceutical manufacturers as well as industrial specialty chemical users.
- Product Portfolio:450+ intermediates
Growth Outlook
Growth is driven by the expansion of its pharmaceutical intermediate portfolio and the increasing demand for specialty chemicals in the cosmetics and agrochemical sectors. The company continues to leverage its R&D capabilities to enter new chemical entities and strengthen its export footprint.
Key Risks
- Regulatory Compliance. The company is subject to stringent environmental and quality regulations in both domestic and international markets, which may impact operational costs.
- Raw Material Price Volatility. Fluctuations in the prices of key chemical feedstocks can significantly impact profit margins due to the company's reliance on global supply chains.
- Customer Concentration. A significant portion of revenue is derived from a limited number of pharmaceutical clients, making the company vulnerable to changes in their procurement strategies.
- Foreign Exchange Risk. As an exporter, the company faces exposure to currency fluctuations that can affect the competitiveness and profitability of its international sales.
Price
Loading…
Start your research today
Unlock AI insights, financials, peers and live data on Ami Organics Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹1,339 Cr
TTM · consolidated
NET PROFIT
₹356 Cr
TTM · consolidated
EPS
₹43.51
TTM · consolidated
RETURN ON EQUITY
25.5%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
33.6%
TTM · consolidated
P/E
27.0x
Q4 FY26 · consolidated
EV/EBITDA
18.1x
Q4 FY26 · consolidated
EBITDA MARGIN
39.0%
TTM · consolidated
NET PROFIT MARGIN
31.0%
Q4 FY26 · consolidated
DEBT TO EQUITY
0.0x
Q4 FY26 · consolidated
Peers · Specialty Chemicals
As of Q4 FY26